ArticleBlood advances2018

Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL.

Ina-Katrin Siekmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.